CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO), specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company is part of the ScaleReady joint venture (with Bio-Techne and Wilson Wolf) and focuses on cancer cell therapies. CellReady is FDA-registered for manufacturing and acquired cell manufacturing assets from Marker Therapeutics for approximately $19 million.
G-Rex cell therapy manufacturing, cell and gene therapy CDMO, cancer cell therapy, CMC expertise
1 site worldwide
No reviews available yet.
No documents available.